SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B7 - Prospectus [Rule 424(b)(7)]:
SEC Accession No. 0001193125-18-255166
Filing Date
2018-08-22
Accepted
2018-08-22 17:02:11
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT d602689d424b7.htm 424B7 234753
2 GRAPHIC g602689g0822040231828.jpg GRAPHIC 2825
3 GRAPHIC g602689g0822040817197.jpg GRAPHIC 2825
  Complete submission text file 0001193125-18-255166.txt   243893
Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B7 | Act: 33 | File No.: 333-213643 | Film No.: 181032999
SIC: 2836 Biological Products, (No Diagnostic Substances)